Aquatic Capital Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $128,380 - $270,060	14,000 New	14,000 $155,000
Q4 2022 Feb 14, 2023	SELL	$11.61 - $16.11 $244,971 - $339,921	-21,100 Reduced 51.59%	19,800 $246,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $371,184 - $598,880	30,400 Added 289.52%	40,900 $571,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $102,193 - $178,269	9,100 Added 650.0%	10,500 $145,000
Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $18,718 - $24,906	1,400 New	1,400 $23,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.